Glenmark Pharmaceuticals consolidated net profit declines 86.23% in the June 2025 quarter
Sales decline 5.09% to Rs 3059.33 crore
Net profit of Glenmark Pharmaceuticals declined 86.23% to Rs 46.87 crore in the quarter ended June 2025 as against Rs 340.27 crore during the previous quarter ended June 2024. Sales declined 5.09% to Rs 3059.33 crore in the quarter ended June 2025 as against Rs 3223.30 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales3059.333223.30 -5 OPM %18.9818.25 -PBDT548.73580.12 -5 PBT418.81462.33 -9 NP46.87340.27 -86Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content